Metabolic effects of clofibrate and of cholestyramine administration to dogs.
D000409:Alanine / Q000378:metabolism; D000818:Animals; D001639:Bicarbonates / Q000096:biosynthesis; D002247:Carbon Isotopes; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000494:pharmacology*; D002994:Clofibrate / Q000494:pharmacology*; D004285:Dogs; D005227:Fatty Acids / Q000096:biosynthesis; D005260:Female; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000032:analysis / Q000096:biosynthesis; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D011773:Pyruvates / Q000378:metabolism; D013268:Stimulation, Chemical
D001639:Bicarbonates; D002247:Carbon Isotopes; D005227:Fatty Acids; D008112:Liver Glycogen; D011773:Pyruvates; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate; D005947:Glucose; D000409:Alanine